Search results
Showing 51 to 62 of 62 results for neuropathic pain
applicable) Source guidance details Comes from guidance Neuropathic pain in adults: pharmacological management in non-specialist...
efficacious. Source guidance details Comes from guidance Neuropathic pain in adults: pharmacological management in non-specialist...
guidance. Source guidance details Comes from guidance Neuropathic pain in adults: pharmacological management in non-specialist settings
This guideline covers care and treatment for adults (aged 18 and over) with type 1 diabetes. It includes advice on diagnosis, education and support, blood glucose management, cardiovascular risk, and identifying and managing long-term complications.
This guideline covers general principles for prescribing and managing withdrawal from opioids, benzodiazepines, gabapentinoids, Z-drugs and antidepressants in primary and secondary care.
CG143/1 | Pain management for patients with an acute painful sickle cell episode:- For patients
Neuropathic pain in adults: pharmacological management in non-specialist settings (CG96)
This guidance has been updated and replaced by NICE guideline CG173.
This guideline covers preventing and managing foot problems in children, young people and adults with diabetes. It aims to reduce variation in practice, including antibiotic prescribing for diabetic foot infections.
NICE has developed a medtech innovation briefing (MIB) on Mobi-C for cervical disc replacement
GID-MT567 Evoke Spinal Cord Stimulator for managing chronic neuropathic or ischaemic pain
In development [GID-MT567] Expected publication date: TBC
This guideline covers care and management for adults (aged 18 and over) with type 2 diabetes. It focuses on patient education, dietary advice, managing cardiovascular risk, managing blood glucose levels, and identifying and managing long-term complications.
How my experience as a patient helped shape NICE guidelines for colorectal cancer
Following my surgery and treatment for colorectal cancer in 2014, I wanted to contribute to research in the cancer field and hopefully improve things for patients in the future, so I applied and was accepted to be a lay member for NICE’s colorectal cancer guideline committee.